US 7718196
Rapamycin-resistant T cells and therapeutic uses thereof
granted A61KA61K2035/122A61K2035/124
Quick answer
US patent 7718196 (Rapamycin-resistant T cells and therapeutic uses thereof) held by The United States of America, as represented by the Department of Health and Human Services expires Mon May 13 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue May 18 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 13 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K2035/122, A61K2035/124, A61K2039/57, A61K2239/31